Navigation Links
Global Leader in Medical Technology Offers for Sale Seven Patent Portfolios Through ICAP Patent Brokerage
Date:10/19/2011

CHICAGO, Oct. 19, 2011 /PRNewswire/ -- ICAP Patent Brokerage, a division of ICAP plc, the world's largest intellectual property brokerage and patent auction firm, is offering for sale seven patent portfolios from a major medical device company. The available portfolios disclose patented technology related to biomaterials, bio-prosthetics, device failure control, high-intensity focused ultrasound (HIFU) energy, improved blood management, medical devices and suction ablation.

(Logo:  http://photos.prnewswire.com/prnh/20100614/CG20517LOGO)

Portfolios Available for Sale:

Biomaterials for Stable Medical Implantable Devices

This portfolio discloses medical devices constructed using biomaterial compounds or biostable polymers such as polyurethanes. Free of ester, ether, and carbonate linkages, the hard or soft segments of the polymers include moieties which reduce susceptibility to both oxidation and hydrolysis.

Bio-Prosthetic Devices & Methods

This portfolio discloses methods for manufacturing materials such as cross-linked collagen-based materials for bio-prosthetic devices, including implants. The technology affords control over the flexibility and stiffness of resulting materials.

Failure Control with Selective Protection of Electronic Components

This portfolio discloses techniques for protecting various electronic components of a device. In the event of device failure, the non-critical components stop the operation of critical components, mitigating damage to the system and/or user.

High Intensity Focused Ultrasound Energy for Ablation

This portfolio discloses devices and techniques for utilizing HIFU energy for localized, controlled tissue ablation. In particular, the disclosed devices can be used to form a customized lesion, or a lesion comprising disconnected lesion segments, applicable to the treatment of multiple diseases.  

Improved Blood Management Techniques

This portfolio discloses devices and techniques for the management of hemostasis. The technology rapidly determines heparin levels in blood or other fluids such as plasma, as well as quantitatively assessing the coagulation process.

Medical Devices & Techniques for Joining Hollow Bodies

This portfolio discloses medical devices and techniques for treating a patient with an anastomosis procedure or other techniques resulting in the joining of two bodies without a suture. In particular, the technology describes securing two hollow bodies using either magnetic or mechanical components.

Suction Ablation Devices & Techniques

This portfolio discloses a medical ablation device that uses a vacuum or suction force in conjunction with ablation element(s) to create lesions in tissue. The suction affords a robust relationship between the ablating element and tissue. This technology is particularly suitable for use with difficult to ablate tissue including tissue that can be expected to move during the ablation process.

"These portfolios feature superlative medical technology developed and refined over the course of decades. They warrant close attention," said Cameron Gray, SVP at ICAP Patent Brokerage.

To learn more about the assets available for license in this portfolio:

Contact Cameron Gray of ICAP Patent Brokerage at (650) 421-3089 or Cameron.Gray@us.icap.com

About ICAP Patent Brokerage

ICAP Patent Brokerage is a division of ICAP plc and the world's largest intellectual property brokerage and patent auction firm.

About ICAP

ICAP is the world's premier interdealer broker and provider of post trade services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, foreign exchange, emerging markets, equities and equity derivatives through voice and electronic networks. ICAP plc was added to the FTSE 100 Index on 30 June 2006. For more information go to www.icap.com.


'/>"/>
SOURCE ICAP Patent Brokerage
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Flow Cytometry: Products, Technologies and Global Markets
2. Aesthetic Lasers and Energy Devices - Global Market Briefing to 2017
3. SomaLogic Announces Research Agreement with Leading Global Pharmaceutical Company to Accelerate Pharmaceutical Discovery and Development
4. The Global Pharmaceutical Fine Chemicals Market Outlook to 2015
5. Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
6. White Smile Global Inc. (WSML) Names Dr. Martin S. Giniger, D.M.D., Ph.D., MsD, FICD New Scientific Director Bringing Decades of Proven Scientific Advancements to Create the All New White Smile™ Organic Product Line
7. UBM Canon, the Global Authority on the Medical Device Industry, Announces Key Hires in the U.S. and Asia to Complement Its Expanding Marketing and Advertiser Media Solutions Team
8. Bare Metal Stents (BMS) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
9. Ophthalmic Diagnostic Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
10. Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
11. Lifebox Global Not-For-Profit Announces American Society of Anesthesiologists Joins Campaign to Improve Surgical Care in Developing Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... Va. , Feb. 12, 2016   National ... Hoey , RPh, MBA issued the following statement today ... released by the Centers for Medicare & ... raised by NCPA, beneficiary advocates and others: ... raised. We are still reviewing the full CMS analysis. ...
(Date:2/12/2016)...  This month,s issue of the Journal of ... in-depth look at various causes and consequences associated with rising health ... which has generated significant public outrage and calls for ... E. Happe , PharmD, MPH. --> JMCP ... --> In 2014 prescription drug spending in ...
(Date:2/12/2016)... PAULO , Feb. 12, 2016 ... commenced a cash tender offer (the "Tender Offer") ... million outstanding aggregate principal amount of its 6.500% ... and ISIN Nos. US44915JAA88/ USP5246AAF05) (the "Notes"). In ... soliciting (the "Consent Solicitation") consents (the "Consents") of ...
Breaking Medicine Technology:
(Date:2/12/2016)... Washington, DC (PRWEB) , ... ... ... the Siemens Foundation today announced a new initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to ... settings. The partnership will recruit top students from U.S. universities who will ...
(Date:2/12/2016)... Boca Raton, FL (PRWEB) , ... February 12, ... ... nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving ... patient services – hosted over 250 members of South Florida’s philanthropic community at ...
(Date:2/12/2016)... ... February 12, 2016 , ... CDRH Enforcement Trends: , Back to the Future , ... , As Winston Churchill said, “Those who don’t learn from history are doomed to ... expect when they come knocking this year. But that takes time. , Take a ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fixed Dose Combination ... 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination , Fixed dose combination ... garnering increased attention from all stakeholders in the development of new chemical entities. ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... Each year, ... will be held in Anaheim, CA at the Anaheim Convention Center. Almost 10,000 physical ... see new therapy products in action, learn more about their chosen field and network ...
Breaking Medicine News(10 mins):